Medical Prognosis Institute A/S - Interim Report First Half 2014 - Allarity Therapeutics

‹ Back

Medical Prognosis Institute A/S – Interim Report First Half 2014

12/08/2014

Hoersholm; April 12th 2014 – Medical Prognosis Institute A/S (MPI) announces the Company’s Interim Report First Half 2014.

Interim Report First Half 2014

The Board of Directors for Medical Prognosis Institute A/S has today discussed and approved the Interim Report First Half 2014.

This announcement contains the full Interim Report First Half 2014.

For further information please contact

Peter Buhl Jensen, CEO

e-mail: [email protected]

Cell Phone: +45 21 60 89 22

Certified Advisor: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark

Sign up for press releases and receive relevant information about Allarity Therapeutics A/S

Press Contact

For any inquiries, please contact:

[email protected]

Newest Press Releases

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Oct 10, 2024

Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program

Oct 03, 2024

Copyright © 2024 Allarity Therapeutics, Inc. All Rights Reserved.

Unless otherwise specified, all product and service name appearing in this internet site are trademark owned by or licensed to Allarity, its subsidiaries or affiliates. No use of any Allarity trademark, trade name, or trade dress in this site may be made without the prior written authorization of Allarity, except to identify the product or services of company.

United States:
24 School Street, 2nd Floor,
Boston, MA 02108
USA
Tel. +1 401-426-4664

Denmark:
Venlighedsvej 1
2970 Hoersholm
Denmark
Tel. +45 88 74 24 14
CVR: 34623562